The Patent Finder

Hyundai Pharm Co., Ltd.

Also on record
Records under this name other than the patents Hyundai Pharm Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 6 patents it holds.

Showing 1 to 3 of 3 · Back to Hyundai Pharm Co., Ltd.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,073,830Compound for inhibiting 11β-hydroxy steroid dehydrogenase 1, and a pharmaceutical composition comprising the same
Lapsed on the fee record
Ended Jul 7, 2023 · USPTO record
Lapsed on the fee recordEnded Jul 7, 2023USPTO record
US 10,292,955Composition for external use preparation with improved transdermal permeability
Lapsed on the fee record
Ended May 21, 2023 · USPTO record
Lapsed on the fee recordEnded May 21, 2023USPTO record
US 9,758,527Cyclohexene derivative, preparation method therefor, and pharmaceutical composition for preventing or treating metabolic diseases, containing same as active ingredient
Lapsed on the fee record
Ended Sep 12, 2021 · USPTO record
Lapsed on the fee recordEnded Sep 12, 2021USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited